Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5201126 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL28385333 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL28387994 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL18301559 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL8658115 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL8657492 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL208982 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL8658364 | 0.86 | KDM4E (0.48) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL8655473 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 | |
| SCHEMBL2262582 | 0.86 | KDM4E (0.43) | KDM4ETDP1ENPP2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117106150-A | Novel 2D polymer, lithium-sulfur battery diaphragm and preparation method and application thereof | 中山大学 | 2023-11-24 | — | — | CN | claimed |
| CN-117106150-A | Novel 2D polymer, lithium-sulfur battery diaphragm and preparation method and application thereof | 中山大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-117106150-A | Novel 2D polymer, lithium-sulfur battery diaphragm and preparation method and application thereof | 中山大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-114478357-B | Halogen bond-containing piezochromic aggregation-induced emission molecule | 江苏新视界先进功能纤维创新中心有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-114478357-A | Halogen bond-containing piezochromic aggregation-induced emission molecule | 江苏新视界先进功能纤维创新中心有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-113717397-B | Preparation method of metal cluster-based crystalline porous material | 暨南大学 | 2022-04-05 | — | — | CN | disclosed |
| CN-114235777-A | Culture-free high-sensitivity Raman detection method for food-borne pathogenic bacteria | 陕西科技大学 | 2022-03-25 | — | — | CN | disclosed |
| US-9586907-B2 | Isothiocyanate compounds, pharmaceutical compositions, and uses thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-03-07 | — | — | US | disclosed |
| US-20150246887-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2015-09-03 | — | — | US | disclosed |
| US-8859798-B2 | Isothiocyanate compounds, pharmaceutical compositions, and uses thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2014-10-14 | — | — | US | disclosed |
| US-8859798-B2 | Isothiocyanate compounds, pharmaceutical compositions, and uses thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2014-10-14 | — | — | US | disclosed |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-11-26 | — | — | US | disclosed |
| US-7569694-B2 | Coumarin compound, material for light emitting device and organic electroluminescent device | CHISSO CORPORATION (JP) | 2009-08-04 | — | — | US | disclosed |
| US-7514158-B2 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2009-04-07 | — | — | US | disclosed |
| US-20070176544-A1 | Coumarin compound, material for light emitting device and organic electroluminescent device | JNC CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20050275341-A1 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2005-12-15 | — | — | US | disclosed |
| US-4656233-A | \"Living\" polymers and chain transfer-regulated polymerization process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0186330-A1 | \"Living\" polymers and chain transfer-regulated polymerization process | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246887-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | TST, TREH, NFATC1 | KDM4E 2319/4885TDP1 3595/4885ENPP2 4411/4885 |
| US-20050275341-A1 | Coumarin compound | XPO1, VKORC1, XPO5 | KDM4E 3068/4885TDP1 3317/4885ENPP2 4840/4885 |
| US-20070176544-A1 | Coumarin compound, material for light emitting device and organic electroluminescent device | TRPA1, CYP3A4, UGT1A10 | KDM4E 2936/4885TDP1 3594/4885ENPP2 4700/4885 |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | TST, TREH, NFATC1 | KDM4E 2319/4885TDP1 3595/4885ENPP2 4411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.